Global Piracy & Counterfeiting Consultants Applauds President Trump for Calling China Out for Their Complicit Involvement in Importing or Smuggling Fentanyl into the USA-This Drug Has Killed 100,000's of US Citizens

"We are applauding US President Donald Trump for taking a hard line on China's dumping their products in the USA including Fentanyl which is responsible for the deaths of 100,000's of US citizens.”

— Global Piracy Counterfeiting Consultants

WASHINGTON , DC, USA, August 23, 2019 / — The Global Piracy & Counterfeiting Consultants says, "We are applauding US President Donald Trump for taking a hard line on China's dumping their products in the USA including Fentanyl which is directly responsible for the deaths of 100,000's of US citizens. Chinese made Fentanyl either makes its way into the USA via the US Postal Service or it comes across the USA's wide-open border with Mexico courtesy of Mexican drug cartels.

"We think President Trump was correct to call out China for their conduct as a business partner as well as to suggest US companies should find a better place to produce or manufacture their products. It is a well known fact that many US companies doing business in China frequently discover–(Big Surprise)—-their products are being counterfeited by the Chinese. Why do business with China?

“On September 11th, 2001-terrorists killed nearly 3000 US citizens. As a result of this attack the US launched the war in Afghanistan and the 9-11 attack also played a role in the US going to war in Iraq. How is Chinese made Fentanyl killing 100,000's of US citizens any different that the terrorist attacks of 9-11? When does China pay the families back for their lost loved one who died of a Chinese made Fentanyl overdose?" https://GP-CC.Com

The Global Piracy and Counterfeiting Consultants has been offering the following services—for nearly a decade—No one in DC ever called.

* “We can assist the US Postal Service from being an unwitting contributor to billions of dollars in counterfeit drugs entering the United States each year by stopping counterfeit narcotics from getting past our international mail terminals.

* “There needs to be an aggressive national media campaign to discourage anyone from buying counterfeit drugs on the Internet. We can put together this coalition. A significant percentage of counterfeit pharmaceutical products being sold on the street or in our schools contain fentanyl.

* “Separate from our efforts the US Congress has to grow a spine and figure out a way to stop Mexican heroin, fentanyl and counterfeit drugs from flooding into the USA along our 2000-mile-long border.” http://GP-CC.Com

On April 15, 2014, the Global Piracy and Counterfeit Consultants warned, “We are not talking about rocket science for the US Postal Service; if they need help, we will train their postal-inspectors-so they know what to look for. Why would the US Postal Service want to support Chinese organized crime, or Chinese counterfeiters? We are also talking about a multi-billion dollar a year industry that has a negative impact on US consumers, major drug companies, and their shareholder’s.” http://GP-CC.Com

Chinese Counterfeit Drugs coming to the USA-Newsweek-2017:

Number of US drug Overdose Deaths 60,000+-CBS News 2017:

Pill Making Press Illegally Being Sent to The United States-CNN-2017:

Mexico’s Contribution to The US Opioid Epidemic: Business Insider-2017: For more information about Mexico’s contribution to the “US Opioid Epidemic” please refer to the following news article:

M. Thomas Martin
Global Piracy Counterfeiting Consultants
+1 866-714-6466
email us here

Source: EIN Presswire

How Intermountain Healthcare Is Making Care Affordable

SALT LAKE CITY, UTAH, USA, August 23, 2019 / — Making healthcare more affordable for the people it serves is a top priority for Intermountain Healthcare.

That's what Intermountain CEO Marc Harrison, MD, said at meetings held this summer with managers from across the Salt Lake City-based health system. Harrison told managers that Intermountain is well-positioned to lead the nation in providing the best care at an affordable cost, and, with the help of each caregiver, it's a goal that can be achieved.

"We have a crisis in American healthcare right now," Dr. Harrison said. "Healthcare is unaffordable. The existing healthcare system is oriented toward driving volume. As an industry we do too many things to too many people that they really don't need, which hurts them economically, and sometimes physically. But Intermountain has a great history of innovation and together we can drive change."

Dr. Harrison shared some alarming national statistics about the cost of healthcare:
• One in four people will forego medical care this year because it's too expensive.
• One in three Americans ration their prescription drugs because they can't afford them.
• About half of Americans worry an unexpected healthcare expense will bankrupt them.
•Healthcare expenses are the number one cause of bankruptcy in the United States

Dr. Harrison says the statistics are better in Utah and Intermountain's charity care program is helping those who can't afford care, but he says more needs to be done. Last year, Intermountain provided more than $246 million in charity care to patients in need of financial assistance.

"We're doing a great job with the cost of healthcare and Intermountain is as competitive and cost-effective as any large system in the United States," he said. "But we have a long way to go and we're going to drive this forward together. How are we going to get there? By keeping people well, by providing the most accessible and affordable care, and by creating a sustainable model."

Examples of innovative solutions at Intermountain that are reducing costs and improving care, which Dr. Harrison shared with managers:

• Civica Rx, the not-for-profit generic drug company banded together by Intermountain and other healthcare systems and philanthropists to fight the skyrocketing cost of prescription drugs by providing low-cost generic drugs to participating hospitals.
• Reimagined Primary Care, the team-based care model that focuses on preventive care to keep patients well. The model already has about 25,000 patient members enrolled and has seen impressive results, such as a 60 percent decrease in hospital admissions, 35 percent decrease in emergency department admissions, and a 20 percent decrease in per member per month costs.
• Addressing social determinants of health such as stable housing, food, transportation, and employment.
• Reducing opioid misuse. Intermountain has reduced the number of opioid tablets prescribed for acute care by more than 30 percent in the last year and is working hard to make further reductions.
• Integrating mental health care into clinics as part of each patient's primary care experience.
• Finding and implementing caregiver ideas. Intermountain caregivers implemented nearly 49,000 continuous improvement ideas in 2018 — more than 130 ideas each day. Many of these ideas both improved quality and reduced expenses.

"We didn't do these things for our self-aggrandizement," Dr. Harrison said. "We did them for our neighbors. And we're in just the right position to continue to be an innovator."

Dr. Harrison added that although helping people stay well and out of the hospital is a key part of Intermountain's strategy moving forward, that doesn't mean we won't continue to provide the best possible hospital care when our patients need it.

"We'll still focus on helping people when they're in a car accident, have a heart attack, or get cancer," he added. "But we have the opportunity to do that in conjunction with a 'keep people well' system. We're still going to have great trauma programs, great heart surgery programs, great cancer care programs, and great neuro ICUs, but won't it be terrific if we can actually keep people out of some of those places? And have them stay as close to home as possible in the least restrictive environment?"

Dr. Harrison emphasized that Intermountain is making changes from a position of strength.

"Intermountain, in a really tough environment, is really doing well. Our quality and safety have never been better. Our patient experience is on the rise. At a time when a lot of other health systems are struggling economically, we're strong. But we need to continually innovate and change to remain a model healthcare system. If not us, who? If not now, when?"

Other things Intermountain and SelectHealth (Intermountain’s insurance arm) are doing to reduce costs and return money to its patients and members:

• Lower annual rate increases. Intermountain reduced annual price increases in 2019 by $15 million.
• Lower-cost care settings. Intermountain is reducing unnecessary ER visits by increasing access to appropriate care in lower-cost settings such as InstaCares (urgent care clinics), physician offices, and Connect Care virtual visits.
• Lower individual premiums. SelectHealth reduced individual plan premiums by an average of 2.7 percent in 2019.
• Affordable SelectHealth Share premiums. Intermountain guarantees a premium rate increase for new clients of SelectHealth Share of only 2.5 percent in years two and three of their three-year contract. For current clients, the guaranteed premium rate increase is only 2 percent for all three years. This compares to an industry-wide premium increase of more than 5 percent.
• Stork Savers. Intermountain's Stork Savers program offers a lower-cost cash price to patients without health insurance for mom and baby care associated with uncomplicated births.
• Supply initiatives. Intermountain has a set ratio between what it pays and what it charges patients for supplies and drugs. When Intermountain reduces its costs, it can directly lower charges to patients for those items. Intermountain negotiated better prices on supplies in 2018 that resulted in more than $32 million in cost savings.
• Financial assistance. Intermountain expanded its financial assistance program to cover needed health services for families with income levels up to 200 percent of the national poverty level. The 2019 national poverty level for a family of four is $25,750.

Intermountain Healthcare is a not-for-profit system of 24 hospitals, 215 clinics, a Medical Group with 2,500 employed physicians and advanced practice clinicians, a health insurance company called SelectHealth, and other health services in Idaho, Utah, and Nevada. Intermountain is widely recognized as a leader in transforming healthcare by using evidence-based best practices to consistently deliver high-quality outcomes and sustainable costs.

Daron Cowley
Intermountain Healthcare
email us here

Source: EIN Presswire

Las Vegas Doctors have special VIP access to worlds largest conference on Aging this October 3-6th at Westgate Resort

Limited number of VIP tickets will be made available for Doctors, Chiropractors, and Regenerative medical clinics
to attend this prestigious event on Aging

One of the most comprehensive conferences on the subject of anti-aging, with a most impressive list of Speakers"”

— Ron Klass Past president A4M

BEVERLY HILLS, CA, USA, August 23, 2019 / —

Las Vegas has been selected to hold the 4th Annual World Conference on Age Reversal and Super Life Extension called RAADfest.

The finest longevity scientists, doctors and thought leaders will present to attendees from over 20 countries and throughout the US at RAADfest, the largest and most prestigious conference on age-reversal in Las Vegas October 3 -6.
A4M past president Ron Klass called RAADfest “one of the most comprehensive on the subject of anti-aging, with a most impressive list of speakers.”

Attendees will learn about cutting edge gene therapy from one of the world’s foremost telomere scientists, Dr. Bill Andrews.

One of the country’s leading experts on anti-aging and nutritional supplementation, Life Extension Magazine Publisher, Bill Faloon, will share advanced research being done on effectively removing damaging senolytic cells (zombie cells), the health benefits this brings, and how practitioners can apply these therapies in their own practice.
RAADfest includes the largest product and services expo of its kind, RAADcity, where the latest solutions will be on on display with free demonstrations, product samples and seminars representing the largest showing of anti-aging products in Las Vegas history.

Limited exhibit space is still available for the most progressive Las Vegas health and wellness companies to showcase their products and services to the biggest audience of dedicated longevity practitioners and consumers in North America. Contact RAADcity Director, Jean Weidmann @ 480-250-1799 for details.

Local doctors, chiropractors, and other medical professional that attend will attain a clear competitive advantage by gaining advanced information and solutions. But only 25 all-access VIP tickets will be made available to licensed Las Vegas medical professionals to attend RAADfest at savings of at least $300. Please call 480-345-6554 or email for details.

Presented by the non-profit Coalition for Radical Life Extension, RAADfest is hosted by its dynamic founders, James Strole and Bernadeane, who are thought-leaders on ageless lifestyle and immortality mindset and Co-Directors of People Unlimited.

Visit to see the schedule of 30 presenters and the vital longevity topics they will cover.

Vincent A Stona
+1 727-726-4746
email us here

Source: EIN Presswire

Global Breast Cancer Therapeutics Market Outlook 2025 adds “Global Breast Cancer Therapeutics Market Outlook 2025” reports to its database.

PUNE, MAHARASHTRA, INDIA, August 23, 2019 / — The global breast cancer therapeutics market is expected to gain massive demand due to rise in the cases of breast cancer. Breast cancer is one of the fatal diseases among cancers and reportedly the second leading cause of death. There are three types of breast cancer – hormone receptor (HR)-positive, triple negative breast cancer (TNBC), and human epidermal growth factor receptor 2 (HER2). The global market is driven by the unusually large number of HR-positive cases.

Rising prevalence of breast cancer due to exposure to estrogens, inheritance due to family medical history, late age of childbirth, and late arrival of menopause are factors touted to augment the breast cancer market size. Changes in lifestyles of patients and the growing aging populace are other drivers of the market. Development of therapeutics for binding tumors to targeted therapies which attack the cancerous cells and makes the environment unhospitable for it to survive. Exposure to carcinogens and unhealthy circadian rhythms are other factors which can increase the probability of cancer and induce market demand. However, patent expiration of blockbuster drugs, high price of therapies, strict regulations regarding approval of vaccines and drugs, and low awareness levels in low-income countries are certain challenges in the market.

Request Free Sample Report @

Precision medicine can gain traction due to tests which can determine the efficacy of certain drugs and therapies according to he genetic makeup of individuals. Breakthroughs in diagnosing procedures can identify patients at a preventive stage and suggest targeted treatments.

The global breast cancer therapeutics market is segmented by drug type. Types of drugs discussed in the market report include aromatase inhibitors, CDK4/6 inhibitors, and HER2 inhibitors. Among these, CDK4/6 inhibitors are used as a part of targeted therapy which are designed to interrupt the growth cycle of enzymes. Development of new drugs which can shut off chemical signals, trigger the immune system, and transportation of toxins to cancerous cells can spur the segment growth in the coming years.

Regions considered in the breast cancer therapeutics market report include Asia Pacific (APAC), Europe, and North America. North America can dominate the global market due to high awareness of the disease and associated medicines, the aging populace, and high reported cases of breast cancer. The U.S., in particular, can contribute the most to the region due to funding from private companies for the development of effective vaccines and drugs. Immense demand for tumor therapeutics can drive the global market.

The APAC region can command a hefty share of the market due to the large patient pool and increasing medical tourism advocating economic treatments. Establishment of oncology units by reputed hospital chains which can invite foreign visitors is likely to bolster the market demand in the coming years. Improvement in healthcare infrastructure, various government initiatives, and growth within the developed economies are other drivers of the regional market.

Development of novel drugs which can be used in combination therapies for providing relief to breast cancer patients during chemotherapy treatments can bode well for the market. Recently, Kalos Therapeutics has signed a Letter of Intent with Oncology Pharma for the development of its drug, KTH 222. The drug can be used with doxorubicin, a drug commonly used in chemotherapy, for treating breast cancer.


For further information on this report, visit –

646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}

Source: EIN Presswire

Citrus Pectin Market 2019 Global Industry Sales, Supply, Consumption, Analysis and Forecasts to 2024

Wiseguyreports.Com Publish Market Research Report On -“Citrus Pectin Market 2019 Global Analysis, Size, Share, Trends, Opportunities and Growth, Forecast 2024”

PUNE, INDIA, August 23, 2019 / —

Citrus Pectin Market 2019

A recent report on WiseGuy Reports (WGR) has provided a brief overview of the industry with an insightful explanation. This summary mentions the definition of the product/service along side many applications of such a product or service in several end-user industries. It additionally includes the analysis of the assembly and management technology utilized for an equivalent. The report on world Citrus Pectin market has given Associate in Nursing in-depth study in some new and outstanding business trends, competitive analysis, and detailed regional analysis for the review period of 2019-2023.

Request Free Sample Report @

Key Players
The report also inculcated detailed profiling of numerous distinguished vendors prevalent in the global Citrus Pectin market. This analysis additionally talks concerning completely different methods adopted by varied market players to achieve a competitive edge over their peers, build unique product portfolios, and expand their reach in the global market.

Market Segment by Manufacturers, this report covers
CP Kelco
DowDuPont (Danisco)
Herbstreith & Fox
Andre Group
Anhui Jinfeng Pectin
Pomona’s Universal Pectin
Anhui Yuning Bio-Technology

Drivers & Constraints
An extensive analysis of the report of the Aluminum Powder market is given, which includes the global presence of crucial driver and constraints that are working in the proliferation of the Citrus Pectin market. The study supported constraints and drivers embody margin of profit, revenues, future aspects, historical growth, sales, and volume. According to these parameters, the opportunities are introduced in the Citrus Pectin market that would escalate the growth during the forecast period. Along with opportunities, there comes challenges, risks, and barriers that could affect the Citrus Pectin market during its growth period. All these parameters with this provide an in-depth understanding of the Citrus Pectin market.

Regional Description
The Citrus Pectin market report’s crucial half additionally includes the regional description that gives an entire analysis of its growth at a worldwide level. The number of crucial regions that the Citrus Pectin marketing research is finished in North America, geographical region, Europe, Asia Pacific, and the Middle East & Africa. These are the top-grossing regions that have discovered the utmost development in each side of technology, businesses, population, industry and more. Therefore, the result of the Citrus Pectin market region-wise portrays the outlook with the latest trends, opportunities, and future aspects in the given assessment period of 2023.

Method of Research
The methodology Citrus Pectin market is done with the help of a compilation of the market information that is explained through known parameters of Porter’s Five Force Model. The current knowledge Associate in Nursing analysis is additionally performed to supply an correct and authentic forecast of the market. The analysis procedure is labelled as intensive, which is categorized into steps such as namely primary and secondary researches. With the assistance of such analysis, the possibility of a better understanding of the market is obtained through a competitive landscape in terms of parameters of weaknesses, strength, threats as well as opportunities related to the industry. This will, hence, bring out the longer term aspects to the business leaders worldwide. The Citrus Pectin market report additionally focuses on varied levels of study like company profile, in progress trends and mechanical system, that comprise of a basic read on the market’s growth, drivers, restraints, challenges, and opportunities.

Complete Report Details @

Table of Contents –Analysis of Key Points
1 Market Overview
2 Manufacturers Profiles
3 Global Citrus Pectin Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
4 Global Citrus Pectin Market Analysis by Regions
5 North America Citrus Pectin by Country
6 Europe Citrus Pectin by Country
7 Asia-Pacific Citrus Pectin by Country
8 South America Citrus Pectin by Country
9 Middle East and Africa Citrus Pectin by Countries
10 Global Citrus Pectin Market Segment by Type
11 Global Citrus Pectin Market Segment by Application
12 Citrus Pectin Market Forecast (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
List of Tables and Figures

Norah Trent
646 845 9349 / +44 208 133 9349
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}

Source: EIN Presswire

Atrial Fibrillation Market Size Worth 13.58 Billion by 2025 | CAGR: 13.5% Infinium Global Research

Atrial Fibrillation Market (Product Type - Access Devices, Cardiac Monitors, EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, LAA Closure, and Other Products; End-user - Hospitals, Electrophysiology Labs, and Ambulatory Surg

Atrial Fibrillation Market

The atrial fibrillation market was valued at around USD 5.7 billion in 2017 and is anticipated to reach USD 13.58 billion by 2025

PUNE, MAHARASHTRA, INDIA, August 23, 2019 / — Infinium Global Research offers Global Atrial Fibrillation Market 2019-2015 research report that profiles atrial fibrillation industry players like CardioFocus, AtriCure, Koninklijke Philips N.V., Biotronik, MicroPort Scientific, and Boston Scientific. The atrial fibrillation market was valued at around USD 5.7 billion in 2017 and is anticipated to reach USD 13.58 billion by 2025, expanding at a CAGR of 13.5% from 2019 to 2025.

Download Free PDF Sample Report@

Rise in Incidences of Obesity, Hypertension, and Diabetes to Propel Growth of Market

The growth of the global atrial fibrillation market is driven by the rising prevalence of atrial fibrillation in a geriatric population. In 2017, According to the Centers for Disease Control and Prevention, 2.7–6.1 million people were suffering from atrial fibrillation in the U.S. Other factors such as poor eating habits, sedentary occupations, and various lifestyle illnesses may surge in cardiac issues, this in turns, driving the atrial fibrillation market. Moreover, the rise in incidences of obesity, hypertension, and diabetes is also fueling the growth of the atrial fibrillation market. On the other hand, the high cost associated with the application of atrial fibrillation devices is expected to hamper the market growth. Furthermore, technological development is seen in the treatment and diagnoses of atrial fibrillation is likely to provide growth opportunities for the atrial fibrillation market in the coming years.

Atrial Fibrillation Market: Segmentation

The report on the global atrial fibrillation market has been broadly segmented into product type, end-users, and application. Based on product type, the market is further bifurcated into access devices, cardiac monitors, EP ablation catheters, EP diagnostic catheters, EP mapping & recording systems, LAA closure, and other products. On the basis of End User, the market is segmented into hospitals, electrophysiology labs and ambulatory surgical center. Based on Application, the global atrial fibrillation industry is divided into surgical, diagnostic and EP ablation.

Ask Discount for the Latest Research Report @

Europe is Dominating the Global Atrial Fibrillation Market

Geographically, Europe is dominating the global atrial fibrillation market due to the high adoption rate of advanced technologies. Germany has a higher role in the atrial fibrillation market, as various catheter ablation procedures are performed in this region. North America is expected to hold the second position in this market over the forecast period owing to well-developed healthcare infrastructures. Moreover, countries such as the U.S. and Canada are a major contributor in North America Atrial fibrillation market. On the other hand, Asia Pacific is anticipated to grow at a CAGR in this market throughout the forecast period. This is due to improvement in healthcare infrastructure and a rise in the prevalence of atrial fibrillation in the geriatric population.

Atrial Fibrillation Market: Competitive Analysis

The market players operating in the global atrial fibrillation industry are facing a higher degree of competition owing to the presence of a large number of vendors. The global atrial fibrillation market comprises with the players such as CardioFocus, Inc., AtriCure, Koninklijke Philips N.V., Biotronik, MicroPort Scientific, Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Johnson & Johnson and Other Companies.

Read Detailed Index of full Research Study at

Infinium Global Research
+91 89999 30634
email us here
Visit us on social media:

Source: EIN Presswire

Global Ambulatory Surgical & Emergency Center Services Market 2019 Share, Trend, Segmentation and Forecast to 2025

Ambulatory Surgical & Emergency Center Services Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025

PUNE, MAHARASHTRA, INDIA, August 23, 2019 / — Ambulatory Surgical & Emergency Center Services Market 2019

Report Details:

This report provides in depth study of “Ambulatory Surgical & Emergency Center Services Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Ambulatory Surgical & Emergency Center Services Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

The global Ambulatory Surgical & Emergency Center Services market is valued at 25800 million US$ in 2018 and will reach 43900 million US$ by the end of 2025, growing at a CAGR of 6.9% during 2019-2025.

The recent report found on the Wise Guy Reports (WGR) website on the Ambulatory Surgical & Emergency Center Services market is a result of an extensive study done by adept analysts. There are several potent figures and facts to grace the report and they have been estimated from data collected by experts for a forecast period 2025. Several prospects in diverse fields have been announced in the report that could impact the current market proceedings and help in decision-making process of various companies. It has historic details, various projections, market dynamics, demographic changes, and others to enable a deep diving into the market.  The report also includes a lot of strategic moves implemented by top-notch market players that could improve individual market stances and assist in the holistic growth of the market. The process also reveals various dynamics of the market interplaying to holistically improve the market forecast. 

The Leading key players covered in this study 
IntegraMed America 
Nueterra Healthcare 
Terveystalo Healthcare 
Symbion, Inc 
AmSurg Corporation 
Medical Facilities Corporation 
Surgery Partners 
Healthway Medical Corporation 

Request a Free Sample Report @

Market split by Type, can be divided into: 
Primary Care Offices 
Emergency Departments 
Surgical Specialty 
Medical Specialty 

Market split by Application, can be divided into: 
Pain Management 

Market segment by Region/Country including: 

This report centers around the worldwide Ambulatory Surgical & Emergency Center Services status, future conjecture, development opportunity, key market and key players. The examination goals are to show the Ambulatory Surgical & Emergency Center Services advancement in North America, Europe, China, Japan, Southeast Asia, India and Central and South America.

Key Stakeholders 
Ambulatory Surgical & Emergency Center Services Manufacturers 
Ambulatory Surgical & Emergency Center Services Distributors/Traders/Wholesalers 
Ambulatory Surgical & Emergency Center Services Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@

Major Key Points from Table of Content:

Chapter 1 Study Coverage
Chapter 2 Executive Summary
Chapter 3 Breakdown Data by Manufacturers
Chapter 4 Breakdown Data by Product
Chapter 5 Breakdown Data by End User
Chapter 6 North America
Chapter 7 Europe 
Chapter 8 Asia Pacific
Chapter 9 Central & South America
Chapter 10 Middle East and Africa
Chapter 11 Company Profiles


Wise Guy Reports
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}

Source: EIN Presswire

Neonatal and Infantcare Products 2019 Global Market Growth, Opportunities and Analysis, Forecast To 2024

This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies

PUNE, INDIA, August 23, 2019 / — According to this study, over the next five years the Neonatal and Infantcare Products market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Neonatal and Infantcare Products business, shared in Chapter 3.

For the study of the global Neonatal and Infantcare Products market, we have considered some of the leading experts from major companies in the industry as well as various other key stakeholders were interviewed. This was done so as to validate and accrue vital information about the market to evaluate potential trends during the forecast period. In order to estimate the global and regional size and valuation of the market, a top-down and bottom-up approach was employed. Add to this, data triangulation techniques and other comparative methodologies are also used for calculating the overall size of the global Neonatal and Infantcare Products market.

This report presents a comprehensive overview, market shares and growth opportunities of Neonatal and Infantcare Products market by product type, application, key companies and key regions.

This study considers the Neonatal and Infantcare Products value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Thermoregulation Device
Phototherapy Device
Monitoring System
Hearing and Vision Screening

Request a Free Sample Report, Click Here @

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Pediatric and Neonatal Clinic
Nursing Home

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
United States
Southeast Asia
Middle East & Africa
South Africa
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GE Healthcare
Inspiration Healthcare
Koninklijke Royal Philips NV
Novos Medical Systems
Weyer GmbH
Fisher&Paykel Healthcare
Fanem Ltda

Table of Contents

Global Neonatal and Infantcare Products Market Growth (Status and Outlook) 2019-2024

1 Scope of the Report
2 Executive Summary
3 Global Neonatal and Infantcare Products by Players
4 Neonatal and Infantcare Products by Regions
5 Americas
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Neonatal and Infantcare Products Market Forecast
11 Key Players Analysis
12 Research Findings and ConclusionList of Tables and Figures


Access Complete Report @

646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}

Source: EIN Presswire

Colorado Mesothelioma Victims Center Now Appeals to A Person in Colorado With Mesothelioma to Not Gamble on Lawyers When They Can Have Direct Access To Attorney Erik Karst of Karst von Oiste for Much Better Compensation

"The more information we can document about a person with mesothelioma exposures to asbestos the better the person's financial compensation settlement results-as we'd like to discuss anytime.”

— Colorado Mesothelioma Victims Center

DENVER, COLORADO , USA, August 23, 2019 / — The Colorado Mesothelioma Victims Center says, "We are appealing to a person with mesothelioma in Colorado or their family members to call us anytime at 800-714-0303 for direct access to famed mesothelioma lawyer Erik Karst of Karst von Oiste. We've seen the Internet ads for 'local mesothelioma lawyer locators' and they are a joke. The best way we know for a person with mesothelioma to get completely shortchanged on their financial compensation is for them to hire a local car accident attorney to try to figure out a mesothelioma complex mesothelioma compensation claim.

"We have endorsed attorney Erik Karst and his remarkable colleagues at the law firm of Karst von Oiste because-one of these remarkable mesothelioma attorneys will come to visit a person with mesothelioma in Colorado in their home for a no obligation discussion about where, how and when they were exposed to asbestos and what a compensation claim with this type of information might be worth.

"As we would like to discuss anytime at 800-714-0303-the law firm of Karst von Oiste sends one of their top attorneys to interview a person with mesothelioma in the person's home to enlighten people. Many other law firms send out a secretary with a contract. We have endorsed the lawyers at Karst von Oiste because they take better care of their clients." https://Colorado.MesotheliomaVictimsCenter.Com

The Colorado Mesothelioma Victims Center is now offering to assist a person with mesothelioma in Colorado recall how, where and when they were exposed to asbestos. As they would like to discuss, "The more information we can document about a person with mesothelioma exposures to asbestos the better the person's potential financial compensation settlement results as we'd like to discuss anytime at 800-714-0303." https://Colorado.MesotheliomaVictimsCenter.Com

The Colorado Mesothelioma Victims Center wants to emphasize theirs is a statewide initiative available to a diagnosed anywhere in Colorado including communities such as Denver, Colorado Springs, Golden Leadville, Brighton, Durango, or Parker.

For the best possible mesothelioma treatment options in Colorado the Colorado Mesothelioma Victims Center strongly recommends the following heath care facility with the offer to help a diagnosed victim, or their family get to the right physicians at this hospital:

The University of Colorado Cancer Center for diagnosed victims in the Centennial State or the victim’s family:

High-risk work groups for exposure to asbestos in Colorado include US Navy Veterans, civilian workers for the Department of Defense, power plant workers, oil refinery workers, miners, manufacturing workers, plumbers, electricians, auto mechanics, machinists, or construction workers. In most instances, these types of workers were exposed to asbestos in the 1950’s, 1960’s, 1970’s, or 1980’s.

The states indicated with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon. However, mesothelioma does happen in Colorado. https://Colorado. MesotheliomaVictimsCenter.Com

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: https://www.cancer. gov/types/mesothelioma.

Michael Thomas
Colorado Mesothelioma Victims Center
+1 800-714-0303
email us here

Source: EIN Presswire

Skincare Global Market 2019: Key Players – L’Oreal, Shiseido, Beiersdorf, Este Lauder, The Clorox Company

Wiseguyreports.Com Adds “Global Skincare Market Analysis 2013-2018 and Forecast 2019-2024” To Its Research Database

PUNE, MAHARASHTRA, INDIA, August 23, 2019 / — Skincare Industry


Skincare is a type of ingredient that locks in moisture inside the skin to maintain healthy and smooth texture of the skin. The global skincare market is thriving on these features. Due to heat and pollution, moisture tries to get out of the body which makes skin dry. Skincare products create a shield on the skin to let the moisture stay inside.

Several factors like investment in innovation, wide-range of product availability, growing pollution, increasing awareness, rising disposable income, and others are playing in favor of the growth of the skincare market. Various companies, across the globe, are also locking horns to stay afloat in the market which is helping in the expansion of the market as a whole. On the other side, tendency to shift towards natural and vegan products are also driving the market towards innovation, which can be considered a good traction for the global skincare market. 


The global skincare market has several market players like L’Oreal, Shiseido, Beiersdorf, Este Lauder, The Clorox Company, L’Occitane en Provence, Natura Cosmticos, Aubrey Organics, Colomer, Colorganics, Esse Organic Skincare, Amway, Arbonne International, Iredale Mineral Cosmetics, Gabriel Cosmetics, Giovanni Cosmetics, The Hain Celestial Group, Yves Rocher, and others.  

Request for Sample Report @


Product type and application are two distinct segments in the global skincare market report. The report aims at a better analysis of various factors that can impact the market in the coming years. This analysis is well-backed by value-wise and volume-wise data.

Based on the product type, the global skincare market can be segmented into facial care, body care, hand care, and others. The facial care segment has substantial market reach. The body care segment is also enjoying high exposure which is why it can hold a substantial market share in the coming years.

Based on the application, the skincare market can be segmented into men, women, and babies. The women segment is having remarkable market growth. The babies segment is also holding substantial market share. 

Regional Analysis:

North America, Europe, South America, Asia Pacific (APAC), and the Middle East & Africa (MEA) are five major regions that have been included in the global skincare market analysis. The region-specific analysis has its eyes set on the global growth pockets that can be analyzed with a background of demographic impacts.

North America and Europe are doing considerably good in the global market owing to their strong market positioning. Several companies are operating out of these regions which ensure strong growth. The US, Canada, Mexico, Spain, France, Italy, Germany, the UK< and others are countries that are contributing to the global market notably. People are well aware of the benefits of these products and high expenditure capacity is helping these regions to expand their market.

The APAC region has China, India, Japan, and others as significant contributors with a huge population which many global players are eyeing and trying to to tap to increase their returns.

Buy Now @


Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
646 845 9349 / +44 208 133 9349
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}

Source: EIN Presswire